Pharming Group(PHGUF)
$1.270.00 (0.00%)
PHGUF
Pharming Group financials statements
$1.27
At close:0.00 (0.00%)
Pharming Group (PHGUF) Income Statement
99 Followers
Pharming Group Income Statement
Last quarter (Q3 2026), Pharming Group's total revenue was €118.36M, an increase of 21.66% from the same quarter last year. In Q3, Pharming Group's net income was €22.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 376.13M | € 297.07M | € 245.32M | € 205.62M | € 198.87M | |
| € 330.63M | € 261.80M | € 220.10M | € 188.06M | € 165.73M | |
| € 309.75M | € 265.47M | € 242.39M | € 169.83M | € 163.52M | |
| Depreciation and Amortization | € 11.22M | € 11.06M | € 15.93M | € 13.19M | € 23.27M |
| € 34.78M | € 7.55M | € 9.88M | € 33.53M | € 33.76M | |
| € 20.88M | € -3.67M | € -4.88M | € 18.23M | € 19.01M | |
| € -8.03M | € -4.83M | € -7.13M | € -3.25M | € 4.07M | |
| € 12.85M | € -8.49M | € -12.01M | € 14.99M | € 23.08M | |
| € 2.97M | € -11.84M | € -10.55M | € 13.67M | € 15.34M | |
| Per Share Metrics | |||||
| Basic EPS | € 0.00 | € -0.02 | € -0.01 | € 0.02 | € 0.02 |
| Diluted EPS | € 0.00 | € -0.02 | € -0.01 | € 0.02 | € 0.02 |
| Weighted Average Shares Outstanding | 721.77M | 689.19M | 821.28M | 883.93M | 876.44M |
| Weighted Average Shares Outstanding (Diluted) | 721.77M | 689.19M | 843.25M | 883.93M | 876.44M |
Currency in EUR

